Shin‐ichiro Ohmura

Low-Dose vs Conventional-Dose Trimethoprim-Sulfamethoxazole Treatment for Pneumocystis Pneumonia in Patients Not Infected With HIV

Tatsuya Nagai, Hiroki Matsui, Haruka Fujioka et al. · CHEST Journal · 2023 · 28 citations · Full text

Successful dose escalation of tofacitinib for refractory dermatomyositis and interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibodies

Shin‐ichiro Ohmura, Toru Yamabe, Taio Naniwa · Modern Rheumatology Case Reports · 2020 · 23 citations

Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study

Shin‐ichiro Ohmura, Taio Naniwa, Shin‐ya Tamechika et al. · Journal of Infection and Chemotherapy · 2019 · 20 citations

Rheumatology, Pneumocystis Jirovecii Pneumonia, Systemic Rheumatic Diseases +8

Successful use of short-term add-on tocilizumab for refractory adult-onset still’s disease with macrophage activation syndrome despite treatment with high-dose glucocorticoids, cyclosporine, and etoposide

Shin‐ichiro Ohmura, Koji Uehara, Toru Yamabe et al. · Modern Rheumatology Case Reports · 2020 · 20 citations

Clinical Immunology, Macrophage Activation, Immunology +22

Factors Associated with <i>Pneumocystis jirovecii</i> Pneumonia in Patients with Rheumatoid Arthritis Receiving Methotrexate: A Single-center Retrospective Study

Shin‐ichiro Ohmura, Yoichiro Homma, Takayuki Masui et al. · Internal Medicine · 2021 · 18 citations · Full text

Inflammation, Rheumatology, Mtx Therapy +15